IRF3 and gastric carcinoma: While earlier studies established HBP21 as a tumor suppressor in hepatocellular and gastric carcinomas [18, 19], recent work revealed its involvement in innate immunity, where it enhances interferon regulatory factor 3 (IRF3) activation during antiviral responses [20].